Granahan Investment Management - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 138 filers reported holding NEOGENOMICS INC in Q3 2016. The put-call ratio across all filers is 0.25 and the average weighting 0.7%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q1 2022$2,976,000
-83.3%
244,924
-53.0%
0.07%
-79.8%
Q4 2021$17,778,000
+11.4%
521,041
+57.5%
0.37%
+20.8%
Q3 2021$15,961,000
-8.5%
330,872
-14.3%
0.30%
-6.8%
Q2 2021$17,444,000
+0.7%
386,187
+7.5%
0.32%
-11.4%
Q1 2021$17,327,000
-30.3%
359,256
-22.2%
0.37%
-34.2%
Q4 2020$24,860,000
+18.5%
461,740
-18.8%
0.56%
-21.6%
Q3 2020$20,985,000
+8.1%
568,857
-9.2%
0.71%
+1.4%
Q2 2020$19,416,000
+14.1%
626,719
+1.7%
0.70%
-23.4%
Q1 2020$17,010,000
-40.7%
616,086
-37.2%
0.92%
-30.7%
Q4 2019$28,704,000
+52.4%
981,348
-0.4%
1.32%
+27.4%
Q3 2019$18,837,000
-8.5%
985,218
+5.0%
1.04%
+2.0%
Q2 2019$20,577,000
+1.2%
937,862
-5.6%
1.02%
-6.9%
Q1 2019$20,335,000
+35.4%
993,904
-16.5%
1.09%
+2.7%
Q4 2018$15,015,000
-21.6%
1,190,698
-4.5%
1.06%
+2.3%
Q3 2018$19,146,000
+20.4%
1,247,327
+2.8%
1.04%
+8.5%
Q2 2018$15,903,000
+74.6%
1,213,014
+8.7%
0.96%
+45.6%
Q1 2018$9,106,000
-6.7%
1,115,974
+1.3%
0.66%
-14.3%
Q4 2017$9,761,000
-17.7%
1,101,653
+3.4%
0.77%
-22.3%
Q3 2017$11,854,000
+30.8%
1,065,082
+5.3%
0.99%
+18.4%
Q2 2017$9,060,000
-12.2%
1,011,124
-22.7%
0.84%
-19.4%
Q1 2017$10,319,000
-48.7%
1,307,879
-44.3%
1.04%
+49.9%
Q4 2016$20,106,000
+19.8%
2,346,105
+14.9%
0.69%
+25.6%
Q3 2016$16,789,000
+4.3%
2,042,505
+2.0%
0.55%
-6.3%
Q2 2016$16,103,000
+34.1%
2,002,805
+12.4%
0.59%
+34.3%
Q1 2016$12,005,000
-17.1%
1,781,135
-3.3%
0.44%
-12.2%
Q4 2015$14,488,000
+38.9%
1,840,975
+1.1%
0.50%
+54.2%
Q3 2015$10,433,000
-0.6%
1,820,717
-6.2%
0.32%
+8.8%
Q2 2015$10,500,000
+83.5%
1,940,929
+58.4%
0.30%
+81.1%
Q1 2015$5,721,000
+8.1%
1,224,979
-3.5%
0.16%
+6.5%
Q4 2014$5,291,000
-24.0%
1,268,806
-5.1%
0.15%
-28.4%
Q3 2014$6,966,000
+64.4%
1,337,115
+4.8%
0.22%
+73.4%
Q2 2014$4,236,000
-3.7%
1,275,893
+0.6%
0.12%
+4.2%
Q1 2014$4,399,000
+17.8%
1,267,661
+22.9%
0.12%
+24.0%
Q4 2013$3,733,000
+219.6%
1,031,131
+164.9%
0.10%
+209.7%
Q3 2013$1,168,000
+21.3%
389,230
+60.9%
0.03%
+10.7%
Q2 2013$963,000241,9500.03%
Other shareholders
NEOGENOMICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Kopp Family Office, LLC 1,046,639$12,8748.15%
Greenhouse Funds LLLP 3,981,003$48,966,3373.62%
First Light Asset Management, LLC 3,028,913$37,255,6303.54%
PERKINS CAPITAL MANAGEMENT INC 193,950$2,3862.36%
EMERALD MUTUAL FUND ADVISERS TRUST 1,557,895$19,162,1091.16%
EMERALD ADVISERS, LLC 1,927,074$23,703,0051.15%
Bullseye Asset Management LLC 163,792$2,0151.12%
FORMULA GROWTH LTD 208,885$2,569,2860.88%
OAK FAMILY ADVISORS, LLC 96,737$1,189,8650.56%
Parkman Healthcare Partners LLC 245,812$3,023,4880.55%
View complete list of NEOGENOMICS INC shareholders